Dual Boost

With the innovative Dual Boost® technology, Spectrum® allows to treat transdermally vascular lesions (telangectasias) in a much more efficient way than the traditional use of a single wavelength.

Dual Boost® permits the combined use of the green light 532nm, more selective for the oxy-hemoglobin, and the infrared light 808/940nm, mainly absorbed by the methemoglobin. The two wavelengths are delivered simultaneously and sequentially in the same handpiece, generating a much more selective photothermolysis.

Courtesy of F. Zini MD



  • info_outline Read More

    The sequential emission with Spectrum® provides the common action of the visible wavelength associated with the infrared wavelength.
    The first part of the visible pulse rises the temperature in the vessel, converting oxy-hemoglobin into methemoglobin increasing the absorption of the second part of the pulse by 500%.
    The visible wavelength allows to obtain a complete coagulation and therefore occlusion inside the vessel, leaving unharmed the tissue around (cutaneous annexes).

    When the infrared light hits the target vessel, it enables the use of inferior fluences with subsequent higher safety for the patient, reducing considerably the risk of complications such as redness, pigmentations or burn. Less side effects means that the patient can go back to everyday activities immediately.

    Thanks to the higher selectivity, the results obtained are better that those brought with the use of a single wavelength.
    With the technology Dual Boost®, Spectrum® brings maximum results in the removal of vascular blemishes in less time than single wavelength systems.
    With the new technology physicians can provide to their patients better comfort, safety and satisfaction.

    Foot Telangectasia - A. Crippa, MD
    Leg Telangectasia - L. Tessari, MD
    Leg telangectasia - A. Crippa, MD

    Courtesy of A. Crippa MD - extracted from ELEA 2018 course


Find your laser

Are you interested in a laser or in an accessory?

commentAsk for consulationcomment

Do you need help? Fill in the form and we will help you solve it.



Some of the information contained in this website are exclusively directed to healthcare professionals, in compliance with art. 21 of the Decree n. 46 of February 24th, 1997 and subsequent modifications and integrations, and the Guidelines of the Italian Ministry of Health of March 28th, 2013. The possibility to continue browsing and access to the content relating to products, technical descriptions and commercial offers is subject to the statement made by the user, under his own responsibility, to be a healthcare professional. The simple visitors will be redirected to institutional page of Eufoton.
Cookie Policy

This website uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Find out more by clicking here. ABILITA or DISABILITA.

By pressing Continue I declare under my own responsibility to be a healthcare provider and continuing to browse I declare to accept the cookie information.

I am a health worker
Continue arrow_forward
I am a visitor
Home arrow_forward